BOSTON SCIENTIFIC CORPORATION Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount
BOSTON SCIENTIFIC CORPORATION (BSX) reported Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount of 68.00 million stockoptions for the 3-month period ending 2011-06-30, per its 10-Q filed 2011-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfNetIncomePerOutstandingUnitAmount · last filed 2011-08-05
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of net income, per outstanding unit, amount for the quarter ending 2011-03-31 was 5500000000.00%, a 5.17% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of net income, per outstanding unit, amount for the quarter ending 2010-09-30 was 6200000000.00%, a 34.78% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of net income, per outstanding unit, amount for the quarter ending 2010-06-30 was 6500000000.00%, a 27.45% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of net income, per outstanding unit, amount for the quarter ending 2010-03-31 was 5800000000.00%.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of net income, per outstanding unit, amount for fiscal 2010 was 6100000000.00%, a 27.08% increase from fiscal 2009.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of net income, per outstanding unit, amount for fiscal 2009 was 4800000000.00%, a 5.88% decline from fiscal 2008.
- BOSTON SCIENTIFIC CORPORATION antidilutive securities excluded from computation of net income, per outstanding unit, amount for fiscal 2008 was 5100000000.00%.
pure
| Period end | Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount 3 month | Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount 6 month | Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount 9 month | Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount 12 month |
|---|---|---|---|---|
| 2011-03-31 | 5500000000.00% 10-Q · filed 2011-05-05 | |||
| 2010-12-31 | 6100000000.00% 10-K · filed 2011-02-17 | |||
| 2010-09-30 | 6200000000.00% 10-Q · filed 2010-11-05 | 6200000000.00% 10-Q · filed 2010-11-05 | ||
| 2010-06-30 | 6500000000.00% 10-Q · filed 2010-08-05 | 6200000000.00% 10-Q · filed 2010-08-05 | ||
| 2010-03-31 | 5800000000.00% 10-Q · filed 2011-05-05 | |||
| 2009-12-31 | 4800000000.00% 10-K · filed 2011-02-17 | |||
| 2009-09-30 | 4600000000.00% 10-Q · filed 2010-11-05 | 5400000000.00% 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | 5100000000.00% 10-Q · filed 2010-08-05 | 5800000000.00% 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | 5100000000.00% 10-K · filed 2011-02-17 |
stockoptions
| Period end | Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount 3 month | Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount 6 month |
|---|---|---|
| 2011-06-30 | 68.00M stockoptions 10-Q · filed 2011-08-05 | 62.00M stockoptions 10-Q · filed 2011-08-05 |
| 2010-06-30 | 65.00M stockoptions 10-Q · filed 2011-08-05 |
USD/shares
| Period end | Antidilutive Securities Excluded from Computation of Net Income, Per Outstanding Unit, Amount 6 month |
|---|---|
| 2010-06-30 | $62000000.00 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |